Handelsbanken Fonder’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
103,967
+17,900
| +21% | +$2.25M | 0.05% | 317 |
|
|
2025
Q1 | $9.52M | Buy |
86,067
+59,200
| +220% | +$6.55M | 0.04% | 344 |
|
|
2024
Q4 | $3.67M | Hold |
26,867
| – | – | 0.01% | 496 |
|
|
2024
Q3 | $3.1M | Buy |
26,867
+4,600
| +21% | +$530K | 0.01% | 530 |
|
|
2024
Q2 | $3.07M | Sell |
22,267
-800
| -3% | -$110K | 0.01% | 488 |
|
|
2024
Q1 | $3.18M | Buy |
23,067
+4,200
| +22% | +$579K | 0.01% | 509 |
|
|
2023
Q4 | $2.49M | Buy |
18,867
+1,500
| +9% | +$198K | 0.01% | 515 |
|
|
2023
Q3 | $1.95M | Hold |
17,367
| – | – | 0.01% | 551 |
|
|
2023
Q2 | $1.64M | Sell |
17,367
-200
| -1% | -$18.9K | 0.01% | 585 |
|
|
2023
Q1 | $1.78M | Buy |
17,567
+4,400
| +33% | +$445K | 0.01% | 555 |
|
|
2022
Q4 | $1.57M | Sell |
13,167
-2,100
| -14% | -$251K | 0.01% | 555 |
|
|
2022
Q3 | $1.62M | Hold |
15,267
| – | – | 0.01% | 556 |
|
|
2022
Q2 | $1.49M | Hold |
15,267
| – | – | 0.01% | 586 |
|
|
2022
Q1 | $1.43M | Buy |
15,267
+5,100
| +50% | +$478K | 0.01% | 668 |
|
|
2021
Q4 | $866K | Sell |
10,167
-7,300
| -42% | -$622K | ﹤0.01% | 970 |
|
|
2021
Q3 | $1.68M | Hold |
17,467
| – | – | 0.01% | 675 |
|
|
2021
Q2 | $1.7M | Sell |
17,467
-600
| -3% | -$58.4K | 0.01% | 676 |
|
|
2021
Q1 | $1.76M | Hold |
18,067
| – | – | 0.01% | 643 |
|
|
2020
Q4 | $1.73M | Sell |
18,067
-201,900
| -92% | -$19.4M | 0.01% | 634 |
|
|
2020
Q3 | $21.2M | Buy |
219,967
+20,000
| +10% | +$1.92M | 0.16% | 138 |
|
|
2020
Q2 | $24.4M | Sell |
199,967
-4,033
| -2% | -$492K | 0.2% | 107 |
|
|
2020
Q1 | $17.7M | Buy |
204,000
+35,000
| +21% | +$3.03M | 0.38% | 72 |
|
|
2019
Q4 | $18.2M | Sell |
169,000
-35,000
| -17% | -$3.76M | 0.31% | 97 |
|
|
2019
Q3 | $18.4M | Buy |
204,000
+27,000
| +15% | +$2.43M | 0.37% | 81 |
|
|
2019
Q2 | $14.9M | Sell |
177,000
-30,000
| -14% | -$2.53M | 0.28% | 100 |
|
|
2019
Q1 | $18.2M | Buy |
207,000
+6,600
| +3% | +$581K | 0.35% | 76 |
|
|
2018
Q4 | $14.3M | Buy |
200,400
+35,400
| +21% | +$2.53M | 0.29% | 96 |
|
|
2018
Q3 | $20.3M | Buy |
165,000
+5,000
| +3% | +$615K | 0.38% | 83 |
|
|
2018
Q2 | $15.7M | Sell |
160,000
-6,000
| -4% | -$589K | 0.31% | 96 |
|
|
2018
Q1 | $13.8M | Buy |
166,000
+14,500
| +10% | +$1.2M | 0.27% | 99 |
|
|
2017
Q4 | $11.8M | Buy |
151,500
+3,500
| +2% | +$272K | 0.26% | 94 |
|
|
2017
Q3 | $9.07M | Hold |
148,000
| – | – | 0.21% | 101 |
|
|
2017
Q2 | $6.81M | Buy |
148,000
+28,000
| +23% | +$1.29M | 0.17% | 113 |
|
|
2017
Q1 | $5.2M | Buy |
120,000
+20,000
| +20% | +$866K | 0.14% | 115 |
|
|
2016
Q4 | $3.87M | Hold |
100,000
| – | – | 0.12% | 119 |
|
|
2016
Q3 | $5.06M | Buy |
100,000
+70,000
| +233% | +$3.54M | 0.15% | 118 |
|
|
2016
Q2 | $1.36M | Buy |
+30,000
| New | +$1.36M | 0.06% | 117 |
|